<?xml version='1.0' encoding='UTF-8'?>
<DOC><DOCNO>WSJ900423-0091</DOCNO><DOCID>900423-0091.</DOCID><HL>   Who's News:   Two of Epitope Inc.'s   Founders, Its Chairman   And President, Resign</HL><DATE>04/23/90</DATE><SO>WALL STREET JOURNAL (J), PAGE B7</SO><CO>   WNEWS EPT</CO><LP>   BEAVERTON, Ore. -- Epitope Inc. said two of its threefounders, Denis R. Burger, chairman, and Michael C. Hubbard,president and chief executive officer, resigned to pursueother business interests.   The biotechnology concern said it named Roger Pringlechairman and Adolph J. Ferro president and chief executiveofficer. Mr. Pringle was an Epitope director; Mr. Ferro wasformerly president of the company's Agritope Inc. unit.</LP><TEXT>   Mr. Burger left to pursue full-time operation of YamhillValley Vineyard and his related wine-distribution business.He will remain a member of the board, and will serve as aconsultant. Mr. Hubbard will pursue other unspecifiedbusiness interests, the company said. He also will remain asa consultant.   A third founder, Andrew Goldstein, remains with thecompany as vice president, product development.   Epitope is developing diagnostic tests for AIDS as well astherapeutic drugs for protozoan diseases. The company also isdeveloping genetically engineered plant varieties through itsAgritope subsidiary.   In its fiscal first quarter ended Dec. 31, the companyposted a net loss of $541,000, or eight cents a share, onrevenue of about $1 million. It had a loss of $870,000, or 18cents a share, on revenue of $544,000 the year earlier.</TEXT></DOC>